Latest Subscription Revenue News

Big moves came from disclosure drama, CEO change news, and one standout software upgrade. While several stocks jumped on results, a few gaps couldn’t hold as traders sold into early strength.

Reckon Limited has reported a robust 66.7% increase in net profit for the 2025 financial year, driven by strong revenue growth and the acquisition of Cashflow Manager. The company maintains its dividend policy amid expanding subscription revenues.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.

Big moves came from consumer fintech names as investors quickly re-priced growth, losses, and capital needs. A capital-raise week also split the market: some raisings steadied prices, others triggered fresh selling.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.

Halo Technologies reports a strategic pivot under new CEO Peter Oxlade, adopting a capital-light B2B model in the UK and expanding its Australian managed funds offering, while maintaining stable subscription revenue despite seasonal headwinds.

Scout Security has completed a strategic merger with Roo Inc, creating a global DIY security platform with nearly a million users, and entered the insurtech sector through a new partnership with Bolt. The company also raised A$400k to support its expanded operations.

Unith Ltd reports a 17% rise in quarterly cash receipts alongside strategic funding and new technology launches, signalling momentum in its AI-driven digital human platform.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

RMA Global Limited has rebranded RateMyAgent to Renowned, integrating Curated Social to enhance its real estate marketing platform. The company’s strategic pivot in the US is paying off with record brokerage deals and strong revenue growth.